The acute chest syndrome of sickle cell disease

Journal of Pediatrics

Volumn 135, Issue 4, 1999, Pages 416-422

  Quinn, Charles T ^a   Buchanan, George R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFOTAXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; DEXAMETHASONE; ERYTHROMYCIN; GLUCOCORTICOID; HEMOGLOBIN; OXYGEN; STEROID;

ANALGESIA; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE COURSE; HUMAN; HYDRATION; INCIDENCE; LUNG DISEASE; OXYGEN THERAPY; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SICKLE CELL ANEMIA; TREATMENT OUTCOME;

EID: 0033497507     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70162-9     Document Type: Article

References (80)

1. 1. Powars D, Weidman JA, Odom-Maryon T, Niland JC, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine 1988;67:66-76.
2. 2. Gray A, Anionwu EN, Davies SC, Brozovic M. Patterns of mortality in sickle cell disease in the United Kingdom. J Clin Pathol 1991;44:459-463.
3. 3. Serjeant GR. Sickle cell disease. Oxford (UK): Oxford; 1986.
4. 4. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994;330: 1639-44.
5. 5. van Agtmael MA, Cheng JD, Nossent HC. Acute chest syndrome in adult Afro-Caribbean patients with sickle cell disease. Arch Intern Med 1994; 154:557-61.
6. 6. Sprinkle RH, Cole T, Smith S, Buchanan GR. Acute chest syndrome in children with sickle cell disease. Am J Pediatr Hematol Oncol 1986;8:105-10.
7. 7. Poncz M, Kane E, Gill FM. Acute chest syndrome in sickle cell disease: etiology and clinical correlates. J Pediatr 1985;107:861-6.
8. 8. Davies SC, Luce PJ, Win AA, Riordan JF. Acute chest syndrome in sickle-cell disease. Lancet 1984;1:36-8.
9. 9. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Blood 1997;89:1787-92.
10. 10. Charache S, Scott JC, Charache P. Acute chest syndrome in adults with sickle cell anemia: microbiology, treatment, and prevention. Arch Intern Med 1979;139:67-9.
11. 11. Martin L, Buonomo C. Acute chest syndrome of sickle cell disease: radiographic and clinical analysis of 70 cases. Pediatr Radiol 1997;27:637-41.
12. 12. Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 1998;92:3082-9.
13. 13. Poncz M, Greenberg J, Gill FM, Cohen A. Hematologic changes during acute chest syndrome in sickle cell anemia. Am J Pediatr Hematol Oncol 1985;7:96-9.
14. 14. Haynes J Jr, Michael BK. The acute chest syndrome of sickle cell disease. Am J Med Sci 1993;305:326-30.
15. 15. Dreyer ZE. Chest infections and syndromes in sickle cell disease of childhood. Semin Respir Infect 1996;11: 163-72.
16. 16. Hassell KL, Eckman JR, Lane PA. Acute, multi-organ failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am J Med 1994;96:155-62.
17. 17. Vichinsky E, Williams R, Das M, Earles AN, Lewis N, Adler A, et al. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994;83:3107-12.
18. 18. Van de Pette JEW, Pearson TC, Slater NGP. Exchange transfusion in life-threatening sickling crises. J R Soc Med 1982;75:777-80.
19. 19. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood 1994;84:643-9.
20. 20. Bowen EF, Crowston JG, De Cuelaer K, Serjeant GR. Peak expiratory flow rate and the acute chest syndrome in homozygous sickle cell disease. Arch Dis Child 1991;66:330-2.
21. 21. Yater WM, Hansmann GH. Sickle cell anemia: a new cause of cor pulmonale. Am J Med Sci 1936;191:474-84.
22. 22. Oppenheimer EH, Esterly JR. Pulmonary changes in sickle cell disease. Am Rev Respir Dis 1971;103:858-9.
23. 23. Barrett-Connor E. Acute pulmonary disease in sickle cell anemia. Am Rev Respir Dis 1971;104:159-65.
24. 24. Barrett-Connor E. Pneumonia and pulmonary infarction in sickle cell anemia. JAMA 1973;224:997-1000.
25. 25. Schulman ST, Bartlett J, Clyde WA Jr, Ayoub EM. The unusual severity of mycoplasmal pneumonia in children with sickle-cell disease. N Engl J Med 1972;287:164-7.
26. 26. Miller ST, Hammerschlag MR, Chirgwin K, Rao SP, Roblin P, Gelling M, et al. Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease. J Pediatr 1991;118:30-3.
27. 27. Kirkpatrick MB, Haynes J Jr, Bass JB Jr. Results of bronchoscopically obtained lower airway cultures from adult sickle cell disease patients with the acute chest syndrome. Am J Med 1991;90;206-10.
28. 28. Godeau B, Schaeffer A, Bachir D, Fleury-Feith J, Galacteros F, Verra F, et al. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med 1996;153:1691-6.
29. 29. Steinberg B. Sickle cell anemia. Arch Pathol 1930;9:876-97.
30. 30. Haupt HM, Moore W, Bauer TW, Hutchins GM. The lung in sickle cell disease. Chest 1982;81:352-7.
31. 31. Bhalla M, Abboud MR, McCloud TC, Shepard J-AO, Munden MM, Jackson SM, et al. Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion. Radiology 1993; 187:45-9.
32. 32. Walker BK, Ballas SK, Burka ER. The diagnosis of pulmonary thromboembolism in sickle cell disease. Am J Hematol 1979;7:219-32.
33. 33. Babiker MA, Obeid HA, Ashong EF. Acute reversible pulmonary ischemia: a cause of the acute chest syndrome in sickle cell disease. Clin Pediatr 1985; 24:716-8.
34. 34. Aldrich TK, Dhuper SK, Patwa NS, Makolo E, Suzuka SM, Najeebi SA, et al. Pulmonary entrapment of sickle cells: the role of regional alveolar hypoxia. J Appl Physiol 1996;80:531-9.
35. 35. Emre U, Miller ST, Gutierez M, Steiner P, Rao SP, Rao M. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr 1995;127:901-4.
36. 36. Mallouh AA, Asha M. Beneficial effect of blood transfusion in children with sickle cell chest syndrome. Am J Dis Child 1988;142:178-82.
37. 37. Warrier RP, Ducos R, Yu LC. Acute chest syndrome in sickle cell disease [letter]. J Pediatr 1986;109:731.
38. 38. Lanzkowsky P, Shende A, Karayalcin G, Kim Y-J, Aballi AJ. Partial exchange transfusion in sickle cell anemia: use in children with serious complications. Am J Dis Child 1978;132: 1206-8.
39. 39. Bodó I, Khoury H, Blinder M. Rapid resolution of the acute chest syndrome of sickle cell disease after automated red cell exchange [abstract]. Blood 1997;90(Suppl 1):23b.
40. 40. Atz AM, Wessel DL. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 1997; 87:988-90.
41. 41. Moser KM, Shea JG. The relationship between pulmonary infarction, cor pulmonale and the sickle states. Am J Med 1957;22:561-79.
42. 42. Diggs LW, Barreras L. Pulmonary emboli vs. pneumonia in patients with sickle cell anemia. Memphis Mid-South Med J 1967;42:375-80.
43. 43. Levy D. The fat embolism syndrome: a review. Clin Orthop 1990;261:281-6.
44. 44. Bulger EM, Smith DG, Maier RV, Jurkovich GJ. Fat embolism syndrome: a 10-year review. Arch Surg 1997;132:435-9.
45. 45. Hulman G. The pathogenesis of fat embolism. J Pathol 1995;176:3-9.
46. 46. Styles LA, Schalkwijk CG, Aarsman AJ, Vichinsky EP, Lubin BH, Kuypers FA. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood 1996;87:2573-8.
47. 47. Chastre J, Fagon JY, Soler P, Fichelle A, Dombret MC, Huten D, et al. Bronchoalveolar lavage for rapid diagnosis of the fat embolism syndrome in trauma patients. Ann Intern Med 1990;113:583-8.
48. 48. Moylan JA, Birnbaum M, Katz A, Everson MA. Fat emboli syndrome. J Trauma 1976;16:341-7.
49. 49. Schuster DP. ARDS: clinical lessons from the oleic acid model of acute lung injury. Am J Respir Crit Care Med 1994;149:245-60.
50. 50. Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med 1995;333:699-703.
51. 51. Gelfand MJ, Daya SA, Rucknagel DL, Kalinyak KA, Paltiel HJ. Simultaneous occurrence of rib infarction and pulmonary infiltrates in sickle cell disease patients with acute chest syndrome. J Nucl Med 1993;34:614-18.
52. 52. Rucknagel DL, Kalinyak KA, Gelfand MJ. Rib infarcts and acute chest syndrome in sickle cell diseases. Lancet 1991;337:831-3.
53. 53. Ballas SK, Park CH. Severe hypoxemia secondary to acute sternal infarction in sickle cell anemia. J Nucl Med 1991;32:1617-8.
54. 54. Palmer J, Broderick KA, Naiman JL. Acute lung syndrome during painful sickle cell crisis: relation to site of pain and narcotic requirement [abstract]. Blood 1983;62:59a.
55. 55. Haynes J Jr, Allison RC. Pulmonary edema: complication in the management of sickle cell pain crisis. Am J Med 1986;80:833-40.
56. 56. Lowenthal EA, Wells A, Emanuel PD, Player R, Prehal JT. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review. Am J Hematol 1996;51:207-13.
57. 57. Kolquist KA, Vnencak-Jones CL, Swift L, Page DL, Johnson JE. Fatal fat embolism syndrome in a child with undiagnosed hemoglobin S/β+ thalassemia: a complication of acute parvovirus B19 infection. Pediatr Pathol Lab Med 1996;16:71-82.
58. 58. Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993;81:1109-23.
59. 59. Schwiebert LM, Beck LA, Stellato C, Bickel CA, Bochner BS, Schleimer RP, et al. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J Allergy Clin Immunol 1996;97:143-52.
60. 60. van den Bosch H, Schalkwijk C, Pfeilschifter J, Marki F. The induction of cellular group II phospholipase A2 by cytokines and its prevention by dexamethasone. Adv Exp Med Biol 1992;318:1-10.
61. 61. Vadas P, Stefanski E, Pruzanski W. Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shock. Agents Actions 1986;19:194-202.
62. 62. Tocker JE, Durham SK, Welton AF, Selig WM. Phospholipase A2-induced pulmonary injury and hemodynamic responses in the guinea pig: effect of enzyme inhibitors and mediators antagonists. Am Rev Respir Dis 1990; 142:1193-9.
63. 63. Peltier LF. The diagnosis and treatment of fat embolism. J Trauma 1971; 11:661-7.
64. 64. Schonfeld SA, Ploysongsang Y, DiLisio R, Crissman JD, Miller E, Hammerschmidt DE. Fat embolism prophylaxis with corticosteroids: a prospective study in high-risk patients. Ann Intern Med 1983;99:438-43.
65. 65. Alho A. Fat embolism syndrome: etiology, pathogenesis, and treatment. Acta Chir Scand Suppl 1980;499:75-85.
66. 66. Griffin TC, McIntire D, Buchanan GR. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med 1994;330:733-7.
67. 67. Isaacs WA, Effiong CE, Ayeni O. Steroid treatment in the prevention of painful episodes in sickle-cell disease. Lancet 1972;1:570-1.
68. 68. Janik J, Seeler RA. Perioperative management of children with sickle hemoglobinopathy. J Pediatr Surg 1980; 15:117-20.
69. 69. Holzmann L, Finn H, Lichtman HC, Harmel MH. Anesthesia in patients with sickle cell disease. Anesth Analg 1969;48:566-72.
70. 70. Spigelman A, Warden MJ. Surgery in patients with sickle cell disease. Arch Surg 1972;104:761-4.
71. 71. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 1995; 333:206-13.
72. 72. Banerjee AK, Layton DM, Rennie JA, Bellingham AJ. Safe surgery in sickle cell disease. Br J Surg 1991;78:516-7.
73. 73. Fullerton MW, Philippart AI, Sarnaik S, Lusher JM. Preoperative exchange transfusion m sickle cell anemia. J Pediatr Surg 1981;16:297-300.
74. 74. Morrison JC, Whybrew WD, Bucovaz ET. Use of partial exchange transfusion preoperatively in patients with sickle cell hemoglobinopathies. Am J Obstet Gynecol 1978;132:59-63.
75. 75. Koshy M, Weiner SJ, Miller ST, Sleeper LA, Vichinsky E, Brown AK, et al. Surgery and anesthesia in sickle cell disease. Blood 1995;86:3676-84.
76. 76. Griffin TC, Buchanan GR. Elective surgery in children with sickle cell disease without preoperative blood transfusion. J Pediatr Surg 1993;28:681-5.
77. 77. Neumayr L, Koshy M, Haberkern C, Earles AN, Bellevue R, Hassell K, et al. Surgery in patients with hemoglobin SC disease. Am J Hematol 1998;57:101-8.
78. 78. Serjeant GR. Chronic transfusion programmes in sickle cell disease: Problem or panacea? Br J Hematol 1997; 97:253-5.
79. 79. Charache S, Terrin ML, Moore RD, Hover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22.
80. 80. Vermylen C, Cornu G. Hematopoietic stem cell transplantation for sickle cell anemia. Curr Opin Hematol 1997;4: 377-80. Chapel Hill, NC 27599-7360.